Paclitaxel/carboplatin with or without belinostat as empiric first-line treatment for patients with carcinoma of unknown primary site: A randomized, phase 2 trial.

导出 LinkOut

翻译打印收藏纠错

作者： John D,Hainsworth ^[1] ; Gedske,Daugaard ; Thierry,Lesimple ; Gerdt,Hübner ; F Anthony,Greco ; Michael J,Stahl ; Christian Meyer Zum,Büschenfelde ; Djelila,Allouache ; Nicolas,Penel ; Poul,Knoblauch ; Karim S,Fizazi

作者单位： Sarah Cannon Research Institute and Tennessee Oncology PLLC, Nashville, Tennessee. ^[1]

关键词 belinostat carboplatin carcinoma of unknown primary site paclitaxel

主题词成年人(Adult);老年人(Aged);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);卡铂(Carboplatin);癌(Carcinoma);无病生存(Disease-Free Survival);用药计划表(Drug Administration Schedule);女(雌)性(Female);组蛋白脱乙酰基酶抑制剂(Histone Deacetylase Inhibitors);人类(Humans);羟肟酸类(Hydroxamic Acids);Kaplan-Meiers评估(Kaplan-Meier Estimate);男(雄)性(Male);中年人(Middle Aged);肿瘤, 未知原发灶(Neoplasms, Unknown Primary);紫杉酚(Paclitaxel);磺胺类(Sulfonamides);治疗失败(Treatment Failure)

DOI 10.1002/cncr.29229

PMID 25611313

发布时间 2022-03-09

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览65

Cancer

2015年121卷10期

1654-61页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Paclitaxel/carboplatin with or without belinostat as empiric first-line treatment for patients with carcinoma of unknown primary site: A randomized, phase 2 trial.

Cancer

相似文献

Cancer

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Paclitaxel/carboplatin with or without belinostat as empiric first-line treatment for patients with carcinoma of unknown primary site: A randomized, phase 2 trial.

Cancer

相似文献

Cancer

相关期刊

检索历史清除